Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | Yes |
Is net profit margin increasing? | Yes | Yes |
Is asset turnover increasing? | Yes | No |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
Novo Nordisk A/S |
Novartis AG |
Orion Oyj |
Sanofi |
AstraZeneca PLC |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
NOVO B | NOVN | ORNAV | SAN | AZN | HLUN A | |||
Return On Equity | ||||||||
Latest Twelve Months | 81% | 26% | 35% | 7% | 18% | 13% | ||
Fiscal Year - 1 | 88% | 16% | 24% | 7% | 16% | 11% | ||
Fiscal Year - 2 | 72% | 10% | 42% | 11% | 9% | 10% | ||
Fiscal Year - 3 | 71% | 37% | 26% | 9% | 0% | 7% | ||
Fiscal Year - 4 | 70% | 14% | 29% | 20% | 22% | 9% | ||
Fiscal Year - 5 | 71% | 11% | 26% | 5% | 10% | 15% | ||
Average | 75% | 19% | 30% | 10% | 12% | 11% | ||
Median | 72% | 15% | 28% | 8% | 13% | 10% | ||
Benchmarks | Ticker | |||||||
Novo Nordisk A/S | CPSE:NOVOB | |||||||
Novartis AG | SWX:NOVN | |||||||
Orion Oyj | HLSE:ORNAV | |||||||
Sanofi | ENXTPA:SAN | |||||||
AstraZeneca PLC | OM:AZN |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | NOVO B | NOVN | ORNAV | SAN | AZN | HLUN A | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 290,403 | 51,722 | 1,542 | 44,286 | 54,073 | 22,004 | ||
Fiscal Year | 290,403 | 51,722 | 1,542 | 44,286 | 54,073 | 22,004 | ||
Fiscal Year - 1 | 232,261 | 46,660 | 1,190 | 41,109 | 45,811 | 19,912 | ||
Fiscal Year - 2 | 176,954 | 43,461 | 1,341 | 40,304 | 44,351 | 18,246 | ||
Fiscal Year - 3 | 140,800 | 43,974 | 1,041 | 39,175 | 37,417 | 16,299 | ||
Fiscal Year - 4 | 126,946 | 49,898 | 1,078 | 37,369 | 26,617 | 17,672 | ||
Fiscal Year - 5 | 122,021 | 48,677 | 1,051 | 37,631 | 24,384 | 17,036 | ||
Net Income | ||||||||
Latest Twelve Months | 100,988 | 11,941 | 330 | 5,496 | 7,035 | 3,143 | ||
Fiscal Year | 100,988 | 11,941 | 330 | 5,496 | 7,035 | 3,143 | ||
Fiscal Year - 1 | 83,683 | 8,568 | 217 | 5,062 | 5,955 | 2,290 | ||
Fiscal Year - 2 | 55,525 | 6,049 | 350 | 7,970 | 3,288 | 1,916 | ||
Fiscal Year - 3 | 47,757 | 22,908 | 194 | 6,223 | 112 | 1,318 | ||
Fiscal Year - 4 | 42,138 | 8,072 | 220 | 12,294 | 3,196 | 1,581 | ||
Fiscal Year - 5 | 38,951 | 7,142 | 200 | 2,855 | 1,335 | 2,313 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 314,486 | 99,945 | 1,439 | 126,464 | 101,119 | 37,407 | ||
Latest Fiscal Quarter | 465,795 | 102,246 | 1,629 | 132,798 | 104,035 | 56,976 | ||
Fiscal Year | 465,795 | 102,246 | 1,629 | 132,798 | 104,035 | 56,976 | ||
Fiscal Year - 1 | 314,486 | 99,945 | 1,439 | 126,464 | 101,119 | 37,407 | ||
Fiscal Year - 2 | 241,257 | 117,453 | 1,504 | 126,722 | 96,483 | 37,452 | ||
Fiscal Year - 3 | 194,508 | 131,795 | 1,114 | 120,242 | 105,363 | 34,653 | ||
Fiscal Year - 4 | 144,922 | 127,778 | 1,116 | 114,413 | 66,729 | 36,029 | ||
Fiscal Year - 5 | 125,612 | 118,370 | 1,036 | 112,630 | 61,377 | 38,133 | ||
Fiscal Year - 6 | 110,769 | 145,563 | 1,147 | 111,408 | 60,651 | 23,011 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 106,561 | 46,667 | 890 | 74,040 | 39,143 | 22,045 | ||
Latest Fiscal Quarter | 143,486 | 44,046 | 1,005 | 77,507 | 40,786 | 25,010 | ||
Fiscal Year | 143,486 | 44,046 | 1,005 | 77,507 | 40,786 | 25,010 | ||
Fiscal Year - 1 | 106,561 | 46,667 | 890 | 74,040 | 39,143 | 22,045 | ||
Fiscal Year - 2 | 83,486 | 59,342 | 908 | 74,784 | 37,037 | 20,779 | ||
Fiscal Year - 3 | 70,746 | 67,655 | 748 | 68,681 | 39,268 | 18,279 | ||
Fiscal Year - 4 | 63,325 | 56,598 | 731 | 63,106 | 15,622 | 16,973 | ||
Fiscal Year - 5 | 57,593 | 55,474 | 779 | 59,056 | 13,127 | 16,782 | ||
Fiscal Year - 6 | 51,839 | 78,614 | 773 | 58,876 | 12,468 | 14,251 |